Pascual-Goñi, E, Caballero-avila, M, Querol, L. Antibodies in Autoimmune Neuropathies. NEUROLOGY. 2024; 103(4)DOI:10.1212/WNL.0000000000209725. PMID:39088795. IF:8.500(Q1/1D).

Baeza, I, de la Serna, E, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, González-Pinto, A, Díaz-Caneja, CM, Corripio, I, Valli, I, Puig, O, Mané, A, Bioque, M, Ayora, M, Bernardo, M, Castro-Fornieles, J. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2024; 33(3)DOI:10.1007/s00787-023-02196-7. PMID:37027026. IF:4.900(Q1/1D).

Fuentes-Claramonte, P, Estradé, A, Solanes, A, Ramella-Cravaro, V, Garcia-Leon, MA, de Diego-Adeliño, J, Molins, C, Fung, E, Valenti, M, Anmella, G, Pomarol-Clotet, E, Oliver, D, Vieta, E, Radua, J, Fusar-Poli, P. Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers. Schizophrenia Bulletin Open. 2024; 5(1)DOI:10.1093/schizbullopen/sgae018. PMID:39228676. IF:(Q/D).

Delaby, C, Teunissen, CE, Blennow, K, Alcolea, D, Arisi, I, Amar, EB, Beaume, A, Bedel, A, Bellomo, G, Bigot-Corbel, E, Bjerke, M, Blanc-Quintin, MC, Boada, M, Bousiges, O, Chapman, MD, DeMarco, ML, D'Onofrio, M, Dumurgier, J, Dufour-Rainfray, D, Engelborghs, S, Esselmann, H, Fogli, A, Gabelle, A, Galloni, E, Gondolf, C, Grandhomme, F, Grau-Rivera, O, Hart, M, Ikeuchi, T, Jeromin, A, Kasuga, K, Keshavan, A, Khalil, M, Kortvelyessy, P, Kulczynska-Przybik, A, Laplanche, JL, Lewczuk, P, Li, QX, Lleo, A, Malaplate, C, Marquie, M, Masters, CL, Mroczko, B, Nogueira, L, Orellana, A, Otto, M, Oudart, JB, Paquet, C, Paoletti, FP, Parnetti, L, Perret-Liaudet, A, Peoc'h, K, Poesen, K, Puig-Pijoan, A, Quadrio, I, Quillard-Muraine, M, Rucheton, B, Schraen, S, Schott, JM, Shaw, LM, Suarez-Calvet, M, Tsolaki, M, Tumani, H, Udeh-Momoh, CT, Vaudran, L, Verbeek, MM, Verde, F, Vermunt, L, Vogelgsang, J, Wiltfang, J, Zetterberg, H, Lehmann, S. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. ALZHEIMERS & DEMENTIA. 2022; 18(10)DOI:10.1002/alz.12545. PMID:34936194. IF:14.000(Q1/1D).